Projects
VETERINARY clinical studies
the following is a non-confidential list of investigator initiated or collaborative veterinary clinical research studies.
Hyperspectral Imaging (disease biomarkers)
Summary: OMG is leading a study in hyperspectral diagnostic imaging of tissue samples in canine and feline patients. Hyperspectral imaging (HSI) is a rapidly emerging, powerful method leverages laser spectroscopy to identify subtle molecular / chemical changes in samples such as tissues or liquid biopsies. More information about this rapidly emerging area of biomedical diagnostics (link).
Sponsor: Biomedical Company (confidential)
Status: Started in 2026
Study Location(s): Arizona Animal Hospital, 31319 N Scottsdale Rd., Scottsdale, AZ 85266
Canine Metabolomics Study
Summary: This study evaluated the effects of an antioxidant formula compared to placebo in dogs over a 6-week period. Dogs were evaluated by the veterinarian (physical exams) and owner (two quality of life surveys). Blood samples were obtained on Day 0 and 42 and used to evaluate changes in chemistry and hematology. Additional serum samples were processed using a refrigerated centrifuge and stored in vapor phase liquid nitrogen for canine metabolomic analysis by a specialized laboratory.
Sponsor: Biomedical Company (confidential)
Status: Completed, 2026
Study Location(s): Arizona Animal Hospital, 31319 N Scottsdale Rd., Scottsdale, AZ 85266
Confocal Laser Endomicroscopy: Developing a Companion Animal Digital Tissue Atlas
Summary: OMG is using a new confocal laser endomicroscope to create a digital image atlas of healthy and diseased tissues in companion animals, which will advance in-vivo microscopic digital pathology for veterinary medicine.
Sponsor: Biomedical Company (confidential)
Active as of: October 2025
Study Location(s): Arizona Animal Hospital, 31319 N Scottsdale Rd., Scottsdale, AZ 85266
Coccidioidomycosis (Valley Fever): Evaluating immune modulators in dogs with Valley Fever
Summary: OMG is preparing to evaluate existing immune modulators in dogs with VF to inform on applications for humans and veterinary patients.
Sponsor: OMG (internal, investigator initiated)
Anticipated Start: November 2025
Study Location(s): Arizona Animal Hospital, 31319 N Scottsdale Rd., Scottsdale, AZ 85266
Read More......
Background: Veterinarians routinely use human antifungal drugs to treat dogs with Valley Fever, as there are no approved veterinary drugs for this condition. There is also a rise in antifungal drug resistance which is of significant concern in human and veterinary medicine. OMG seeks to leverage the immune system to help fight infection, based on a growing body of evidence immune modulation can shorten the duration of VF, even in patients that are severely ill and refractory to antifungal therapy.
Study: This study will evaluate clinical and immunological responses in dogs administered orally bioactive immune modulators in conjunction with antifungal therapy.
Immune Modulators: OMG has selected immune modulators with comparable mechanisms of actions in people and dogs, making this study highly translatable.
Eligibility: Dogs with diagnosed with Valley Fever that are over 1 year of age with clinical signs of disease (e.g., coughing, limping, fever, lethargy).
Owner responsibilities: Owners will receive treatments (e.g., fluconazole plus an immune modulator) at no cost for the first 30 days.
Owners will be responsible for the cost of routine (standard of care) exams and bloodwork (e.g., Valley Fever titers) which will be explained during the first visit.
VETERINARY
biobank
OMG is creating a canine serum biorepository from dogs that have comparative diseases to humans for secondary research purposes with collaborators.
OMG is creating a veterinary biosample repository (serum, plasma) with a focus on:
- Canine Coccidioidomycosis
- Canine Cancer
- Canine Allergic Dermatitis
The veterinary biorepository is intended to support collaborations in comparative multi-omics, development of diagnostics, and other collaborative research projects.